Ki67 is a proliferation marker that provides information about tumor aggressiveness (Lukasiewicz et al., 2021; Nielsen et al., 2021; Parekh et al., 2018), treatment response, and recurrence risk (Lukasiewicz et al., 2021). This evidence concerns the gene MKI67 and neoplasm.